Core Viewpoint - The company is expanding its product chain and enhancing its competitive capabilities in the industry through the acquisition of a 70% stake in He Yu Tai from Xin He Bio, which is expected to be completed by November 18, 2025 [1] Group 1: Acquisition Details - The acquisition will be financed through self-owned funds and a bank loan amounting to 153.86 million yuan [1] - After the acquisition, He Yu Tai will become a controlled subsidiary of the company and will be included in the consolidated financial statements [1] Group 2: Strategic Importance - The acquisition aligns with the company's established development strategy of vertically extending its industrial chain [1] - The target company has extensive experience in the agrochemical sector, with a diverse product portfolio including herbicides, fungicides, and plant growth regulators, showcasing certain advantages in products, technology, and market presence [1] Group 3: Market Entry Advantages - The target company has successfully obtained registration certificates for multiple pesticide active ingredients in key domestic and overseas markets [1] - Directly acquiring the target company allows the listed company to bypass lengthy and costly pesticide registration processes, saving at least 2-3 years in registration time and enabling quicker market entry to seize opportunities [1]

每经头条（nbdtoutiao）——段睿：我与蔡磊是 "找钥匙的人"，纵使生前寻不到，也要为其他渐冻症患 者铺就近路 每经AI快讯，巍华新材（SH 603310，收盘价：17.96元）11月18日晚间发布公告称，公司第五届第二次 董事会会议于2025年11月18日在公司301会议室以现场投票及通讯表决相结合方式召开。会议审议了 《关于控股子公司收购江苏禾裕泰化学有限公司70%股权并签署<股权转让协议>的议案》等文件。 2024年1至12月份，巍华新材的营业收入构成为：氟精细化工行业占比99.03%，其他业务占比0.97%。 截至发稿，巍华新材市值为62亿元。 （记者 王晓波） ...

Core Viewpoint - The company, Wihua New Materials, is acquiring a 70% stake in Jiangsu Heyutai Chemical from Zhejiang Xinhhe Biological for a transaction price of 154 million yuan, aiming to turn the target company profitable by 2026 [1] Group 1: Acquisition Details - The acquisition will be funded through the company's own funds and bank loans [1] - After the acquisition, Heyutai will become a controlled subsidiary of Wihua New Materials [1] Group 2: Financial Performance of Target Company - Heyutai is currently in a loss-making phase due to low market prices for agricultural chemical products and insufficient capacity utilization [1] - However, there are signs of improvement, with losses in the first half of 2025 narrowing compared to the same period last year, and further operational improvements expected in the third quarter [1] Group 3: Future Strategy - Post-acquisition, the company plans to expand sales channels, enhance capacity utilization, optimize product processes, and strengthen internal management to achieve profitability for Heyutai by 2026 [1] - The target company relies on three main raw materials that are also key products of Wihua and its subsidiaries, allowing for stable supply and reduced procurement uncertainties [1]

Core Viewpoint - The company, Wihua New Materials, is acquiring a 70% stake in Jiangsu Heyutai Chemical from Zhejiang Xinhhe Biological for a cash consideration of 154 million yuan, aiming to enhance operational efficiency and profitability in the long term [1] Group 1: Acquisition Details - The acquisition will be funded through the company's own funds and bank loans [1] - After the transaction, Heyutai will become a controlled subsidiary of Wihua New Materials [1] Group 2: Financial Performance of Target Company - Heyutai is currently in a loss-making phase due to low market prices for agricultural chemical products and insufficient capacity utilization [1] - However, there are signs of improvement, with losses in the first half of 2025 narrowing compared to the same period last year, and further operational improvements expected in the third quarter [1] Group 3: Future Strategy - The company plans to expand sales channels, improve capacity utilization, optimize product processes, and strengthen internal management to achieve profitability for Heyutai by 2026 [1] - The acquisition will provide stable supply support for three key raw materials used by Heyutai, which are also major products of the listed company and its subsidiaries, reducing uncertainty in external procurement [1]

Core Viewpoint - The company, Wihua New Materials, plans to acquire a 70% stake in He Yutai for 154 million yuan, indicating a strategic move to expand its business portfolio and enhance market presence [1] Group 1: Acquisition Details - The acquisition amount is set at 154 million yuan, which reflects the company's commitment to growth through strategic investments [1] - The target company, He Yutai, is expected to complement Wihua New Materials' existing operations, potentially leading to synergies and increased market share [1] Group 2: Strategic Implications - This acquisition aligns with the company's long-term strategy to diversify its offerings and strengthen its competitive position in the materials industry [1] - The move is anticipated to enhance the company's capabilities and operational efficiency, contributing to future revenue growth [1]

Group 1 - The core viewpoint of the news is that Zhejiang Weihua New Materials Co., Ltd. is experiencing significant fluctuations in its stock performance and financial metrics, with a notable decrease in revenue and net profit year-on-year [1][2]. Group 2 - As of November 11, 2023, Weihua New Materials' stock price decreased by 0.49%, with a trading volume of 56.75 million yuan. The financing buy-in amount was 8.20 million yuan, while the financing repayment was 5.97 million yuan, resulting in a net financing buy-in of 2.23 million yuan [1]. - The total balance of margin trading for Weihua New Materials reached 123 million yuan, accounting for 3.66% of its circulating market value, which is above the 80th percentile of the past year [1]. - The company has not engaged in any short selling activities on November 11, 2023, with a short selling balance of 0 shares, indicating a high level of confidence among investors [1]. Group 3 - As of September 30, 2023, the number of shareholders for Weihua New Materials was 19,900, a decrease of 1.68% from the previous period. The average circulating shares per person increased by 1.71% to 9,287 shares [2]. - For the period from January to September 2025, Weihua New Materials reported a revenue of 660 million yuan, a year-on-year decrease of 15.18%. The net profit attributable to the parent company was 109 million yuan, down 40.96% year-on-year [2]. Group 4 - The company has distributed a total of 242 million yuan in dividends since its A-share listing [3].

Group 1 - The company, Wihua New Materials, announced the convening of a staff representative assembly on November 7, 2025, which complies with relevant regulations [2] - During the assembly, Mr. Pan Qiangbiao was elected as the employee representative director for the company's fifth board of directors [2]

Core Viewpoint - Wihua New Materials (603310) announced the appointment of Shen Yonghu as the securities affairs representative on the evening of November 7 [1] Group 1 - The company has made a significant personnel change by hiring a new securities affairs representative [1]

证券代码：603310 证券简称：巍华新材 公告编号：2025-060 浙江巍华新材料股份有限公司 关于董事会完成换届选举及聘任高级管理人员、证券事务代表的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江巍华新材料股份有限公司（以下简称"公司"）于 2025 年 11 月 7 日召 开 2025 年第一次临时股东会，选举产生公司第五届董事会非独立董事 3 名、独 立董事 3 名，前述董事与公司职工代表大会选举产生的 1 名职工代表董事共同组 成公司第五届董事会。同日，公司召开第五届董事会第一次会议，选举产生第五 届董事会董事长、副董事长和各专门委员会委员，并聘任了高级管理人员和证券 事务代表。现将具体情况公告如下： 一、公司第五届董事会组成情况 公司第五届董事会成员为吴江伟先生、潘强彪先生、吴顺华先生、刘波平先 生、张增英先生、刘翰林先生、邓鸣先生。其中吴江伟先生为董事长，潘强彪先 生为副董事长、职工代表董事，张增英先生、刘翰林先生、邓鸣先生为独立董事。 | 董事会专门委员会名称 | 委员会委员 | 召集人 | | ...

证券代码：603310 证券简称：巍华新材 公告编号：2025-058 本次选举职工董事工作完成后，潘强彪先生将与公司 2025 年第一次临时股 东会选举产生的 3 名非独立董事和 3 名独立董事共同组成公司第五届董事会，公 司第五届董事会成员由 7 人组成。公司第五届董事会中兼任公司高级管理人员以 及由职工代表担任的董事人数总计未超过公司董事总数的二分之一，符合有关法 律法规、规范性文件及《公司章程》的规定。 2025 年 11 月 8 日 浙江巍华新材料股份有限公司 关于选举职工代表董事的公告 附件：个人简历 潘强彪先生，1977 年 10 月出生，中国国籍，无境外永久居留权，博士研究 生学历，正高级工程师。曾任上海奥博生物医药技术有限公司常务副总经理，联 化科技股份有限公司医药研发副总裁，联化科技（台州）有限公司执行董事兼总 经理，联化科技股份有限公司医药事业部运营总经理，联化科技股份有限公司高 级副总裁，浙江巍华新材料股份有限公司总经理、副董事长，浙江方华化学有限 公司董事。现任公司职工代表董事、浙江巍兰制冷新材料有限公司董事。 截至本公告披露日，潘强彪先生直接持有公司股份 3,300,000 股，占 ...